John J. Orloff

Insider Reports History

Entity
Individual
Location
C/O Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn, IL
Signature
By: /s/ Chase Jayasekera, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John J. Orloff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zenas BioPharma, Inc. Director Stock Option (Right to Buy) 18.5K Sep 12, 2024 Direct
ALEXION PHARMACEUTICALS, INC. EVP, Research & Development Common Stock, par value $.0001 per share 0 $177.00 Jul 21, 2021 Direct

Insider Reports Filed by John J. Orloff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZBIO Zenas BioPharma, Inc. Sep 12, 2024 1 $0 4 Sep 16, 2024 Director
ZBIO Zenas BioPharma, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director
ALXN ALEXION PHARMACEUTICALS, INC. Jul 21, 2021 1 $0 4 Jul 23, 2021 EVP, Research & Development
ALXN ALEXION PHARMACEUTICALS, INC. Jul 14, 2021 2 $0 4 Jul 16, 2021 EVP, Research & Development
ALXN ALEXION PHARMACEUTICALS, INC. Jun 8, 2021 1 -$346K 4 Jun 9, 2021 EVP, Research & Development